Ghent University Academic Bibliography

Miscellaneous

Molecular therapies and vaccines face the challenges of emerging infectious diseases

Ami Patel, David Weiner, Weidong Xiao, Andrew Baker and Niek Sanders (UGent)

(2022) MOLECULAR THERAPY. 30(5). p.1789-1790

Journal Article
A1
open access

A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity

Séan Mc Cafferty (UGent) , A. K. M. Ashiqul Haque, Aster Vandierendonck, Brian Weidensee, Magalie Plovyt, Magdalena Stuchlikova, Nathalie François (UGent) , Sophie Valembois, Leo Heyndrickx, Johan Michiels, et al.

(2022) MOLECULAR THERAPY. 30(9). p.2968-2983

Add to list

In Vivo Validation of a Reversible Small Molecule-Based Switch for Synthetic Self-Amplifying mRNA Regulation

Séan Mc Cafferty (UGent) , Joyca De Temmerman (UGent) , Tasuku Kitada, Jacob R. Becraft, Ron Weiss, Darrell J. Irvine, Mathias Devreese (UGent) , Siegrid De Baere (UGent) , Francis Combes (UGent) and Niek Sanders (UGent)

(2021) MOLECULAR THERAPY. 29(3). p.1164-1173

Add to list

Corticosteroids and cellulose purification improve, respectively, the in vivo translation and vaccination efficacy of sa-mRNAs

Zifu Zhong (UGent) , Séan Mc Cafferty (UGent) , Lisa Opsomer (UGent) , Haixiu Wang (UGent) , Hanne Huysmans, Joyca De Temmerman (UGent) , Stefan Lienenklaus, João Portela Catani (UGent) , Francis Combes (UGent) and Niek Sanders (UGent)

(2021) MOLECULAR THERAPY. 29(4). p.1370-1381

Add to list

Corticosteroids and mRNA vaccines : a word of caution

Zifu Zhong (UGent) , Francis Combes (UGent) and Niek Sanders (UGent)

(2021) MOLECULAR THERAPY. 29(3). p.893-894

Add to list

Miscellaneous
open access

Low-dose single-shot COVID-19 mRNA vaccines lie ahead

Niek Sanders (UGent)

(2021) MOLECULAR THERAPY. 29(6). p.1944-1945

Add to list

Early signs of clinical activity in Aml patients receiving NKG2D CAR T cell therapy in the absence of pre-conditioning chemotherapy : an alternative strategy to CAR T cell therapy

Eytan Breman, David A Sallman, Jason B Brayer, Xavier Poire, Tessa Kerre (UGent) , Philippe Lewalle, Eunice S Wang, Bikash Verma, Marco L Davila, Nathalie Braun, et al.

(2018) MOLECULAR THERAPY. 26(5, suppl. 1). p.440-440

Add to list

Journal Article
A1
open access

Modulation of protein-protein interactions for the development of novel therapeutics

Ioanna Petta (UGent) , Sam Lievens (UGent) , Claude Libert (UGent) , Jan Tavernier (UGent) and Karolien De Bosscher (UGent)

(2016) MOLECULAR THERAPY. 24(4). p.707-718

Add to list

Type I interferons interfere with the capacity of mRNA lipoplex vaccines to elicit cytolytic T cell responses

Ans De Beuckelaer (UGent) , Charlotte Pollard (UGent) , Sandra Van Lint (UGent) , Kenny Roose (UGent) , Lien Van Hoecke (UGent) , Tom Naessens (UGent) , Vimal Kumar Udhayakumar (UGent) , Muriel Smet, Niek Sanders (UGent) , Stefan Lienenklaus, et al.

(2016) MOLECULAR THERAPY. 24(11). p.2012-2020

Add to list

Coadministration of a plasmid encoding HIV-1 Gag enhances the efficacy of cancer DNA vaccines

Laure Lambricht, Kevin Vanvarenberg, Ans De Beuckelaer (UGent) , Lien Van Hoecke (UGent) , Johan Grooten (UGent) , Bernard Ucakar, Pascale Lipnik, Niek Sanders (UGent) , Stefan Lienenklaus, Véronique Préat, et al.

(2016) MOLECULAR THERAPY. 24(9). p.1686-1696

Academic Bibliography

Molecular therapies and vaccines face the challenges of emerging infectious diseases

A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity

In Vivo Validation of a Reversible Small Molecule-Based Switch for Synthetic Self-Amplifying mRNA Regulation

Corticosteroids and cellulose purification improve, respectively, the in vivo translation and vaccination efficacy of sa-mRNAs

Corticosteroids and mRNA vaccines : a word of caution

Low-dose single-shot COVID-19 mRNA vaccines lie ahead

Early signs of clinical activity in Aml patients receiving NKG2D CAR T cell therapy in the absence of pre-conditioning chemotherapy : an alternative strategy to CAR T cell therapy

Modulation of protein-protein interactions for the development of novel therapeutics

Type I interferons interfere with the capacity of mRNA lipoplex vaccines to elicit cytolytic T cell responses

Coadministration of a plasmid encoding HIV-1 Gag enhances the efficacy of cancer DNA vaccines

Contents

Support

Contact